Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 416
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01948128 | Effects of Vitamin D in Patients With Breast Cancer | ||
| NCT05515354 | Smoking Cessation and Menstrual Cycle Phase | ||
| NCT02501031 | Flaxseed Intervention Study to Assess Sex Hormone Levels Among Post-Menopausal Women | ||
| NCT02788773 | Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer | ||
| NCT00162929 | Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe) | ||
| NCT01296893 | Can Exercise Improve Cancer Associated Cognitive Dysfunction? | ||
| NCT01591421 | P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer. | ||
| NCT02502266 | Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer | ||
| NCT06781762 | Short-term Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer | ||
| NCT06630273 | Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics | ||
| NCT03258554 | Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin | ||
| NCT00064194 | Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia | ||
| NCT00002864 | Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer | ||
| NCT06880523 | STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma | ||
| NCT00005974 | Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma | ||
| NCT00956384 | One-stage Breast Reconstruction Using Dermal Matrix/Implant Versus Two-stage Expander/Implant Procedure | ||
| NCT02750826 | Breast Cancer WEight Loss Study (BWEL Study) | ||
| NCT00080912 | Single vs Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases | ||
| NCT00093457 | Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer | ||
| NCT03917082 | Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer | ||
| NCT01622543 | Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer | ||
| NCT01846390 | Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma | ||
| NCT02459301 | A Dose-Ranging Study of IPH2201 in Patients With Gynecologic Malignancies | ||
| NCT04650581 | Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor | ||
| NCT05887102 | Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors | ||
| NCT00053781 | Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma | ||
| NCT00005957 | Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer | ||
| NCT00307229 | Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1) | ||
| NCT00002561 | Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease | ||
| NCT03568422 | CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer | ||
| NCT00688246 | Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3 | ||
| NCT02821013 | Duration of Anti-PD-1 Therapy in Metastatic Melanoma | ||
| NCT00504296 | SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors | ||
| NCT01627054 | A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia | ||
| NCT00066573 | Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer | ||
| NCT00516828 | Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome | ||
| NCT02719977 | A Phase I Study of CX5461 | ||
| NCT00674830 | Self-help Treatment for Insomnia in Breast Cancer Patients | ||
| NCT00078949 | Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma | ||
| NCT04000776 | 3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer | ||
| NCT03477591 | Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening Decisions | ||
| NCT04224974 | Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia | ||
| NCT00169845 | Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients | ||
| NCT00490139 | ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D | ||
| NCT00438958 | Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases | ||
| NCT03385655 | Prostate Cancer Biomarker Enrichment and Treatment Selection | ||
| NCT03031821 | Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome | ||
| NCT06776458 | Chronic Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer | ||
| NCT01396408 | A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours | ||
| NCT00075660 | 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma |
